secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0000883984-24-000004
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical Q4 revenue up slightly but net loss widens; provides FY2024 guidance
--------------------------------------------------------------------------------

- Revenue $587.9M in Q4 2023, up 1.7% YoY from $578.0M.
- GAAP net loss $17.1M ($0.71/share) widened from $15.5M loss ($0.65/share) in Q4 2022.
- Adjusted EBITDA $86.3M vs $96.4M YoY; adjusted EPS $1.57 vs $1.60.
- Gross margin slipped to 29% from 30%; gross profit $171.6M vs $174.9M.
- Company issued FY2024 guidance (not detailed in excerpt).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398424000004/0000883984-24-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398424000004/icui-20240227.htm
  HTML page:      https://secwatch.observer/filing/0000883984-24-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer